Strength
.5 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378751835
Classification
Generic
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
4/22/2026
Active Ingredients
DIFLUPREDNATEApproval Type
Generic (ANDA)
FDA Application
ANDA212566On Market Since
9/26/2025
Related Drugs
Same classification
No related drugs found.